Source: Business Standard
Mumbai: Shares of Sai Life Sciences jumped 5.1% on Friday Friday June 20, 2025, hitting an intraday high of ₹766.55 on the Bombay Stock Exchange (BSE). Investors were exhibiting strong interest in Sai Life Sciences as more than 20.9 million shares traded by 10:51 AM.
Later in the day, the stock backed off the high and was trading at ₹737.30. Still, this was up 1.11% from the previous close. The BSE Index (Sensex) was also up 0.83% at 82,040.39 points.
The market value of Sai Life Sciences was approximately ₹15,371.64 crore. The 52-week high for the stock is ₹808.20 per share, and the 52-week low is ₹635.30 per share.
Blockbuster Block Deal Behind the Move
Per Bloomberg data, a block trade happened for 20.8 million shares, roughly 10% of the equity. The participants have not been disclosed.
Market rumors suggest that TPG Asia, a private equity firm, may have sold off a 6% stake in the company at ₹710 through this block trade deal at a price of ₹710, which comes in 2.6% below the last close price.
As of the last filing on March 31, 2025, TPG Asia owned a 24.73% stake in Sai Life Sciences and another foreign investor HBM Private Equity India owned 1.99%, according to stock exchange data.
Strong Financial Results Support Share Price
Sai Life Sciences released strong results:
- Net profit for the January-March 2025 quarter rose 57.26% to ₹88.27 crore, compared to ₹56.13 crore, year on year.
- Revenue for the quarter increased 31.94%, to ₹579.51 crore, from ₹439.21 crore.
- For the full year ending March 2025, net profit more than doubled to ₹170.13 crore, from ₹82.81 crore last year. Annual revenue rose 15.66%, to ₹1,694.57 crore.
About Sai Life
Sai Life Sciences is located in Hyderabad, India, and collaborates with global pharma and biotech organizations. Sai Life Sciences provides end-to-end services for drug research, development, and manufacturing. Sai Life can support chemistry, manufacture drug ingredients, and accommodate clinical and commercial activities with advanced technologies.
Future Outlook
There’s been heightened trading activity and a recent block deal in Sai Life Sciences shares. Investors are increasingly confident in shares in Sai Life Sciences after solid financial results, trading activity, and a block deal. But market observers are going to take note on how the shareholding changes will impact the shares going forward.
